DOXGX | LGVAX | DOXGX / LGVAX | |
Total Expense Ratio | 0.41 | 1.01 | 41% |
Annual Report Gross Expense Ratio | 0.46 | 1.04 | 44% |
Fund Existence | 3 years | 16 years | - |
Gain YTD | 8.021 | 4.629 | 173% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 117B | 3.88B | 3,013% |
Annual Yield % from dividends | 1.47 | 0.77 | 190% |
Returns for 1 year | 6.86 | 0.87 | 791% |
Returns for 3 years | 31.09 | 17.77 | 175% |
Returns for 5 years | N/A | 33.42 | - |
Returns for 10 years | N/A | 55.35 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CRRYX | 14.49 | 0.11 | +0.76% |
Columbia Small Cap Value II Inst3 | |||
DBOYX | 25.34 | 0.10 | +0.40% |
BNY Mellon Balanced Opportunity Y | |||
GFVIX | 16.06 | 0.06 | +0.37% |
Goldman Sachs Focused Value Inv | |||
HFYCX | 12.54 | -0.02 | -0.16% |
Hartford Schroders Intl Multi-Cp Val C | |||
RRIGX | 21.75 | -0.04 | -0.18% |
T. Rowe Price International Value Eq R |